office of Medical Policy / FDA / FDA Science Board / office of Compliance and Biologics Quality / FDA Science Board Advisory Committee / Center for Drug Evaluation and Research / office of New Drugs / office of Drug Safety / Center for Biologics Evaluation and Research / /
Person
Drug Safety Janet Woodcock / Rachel E. Behrman / Theresa M. Mullin / Drugs Janet Woodcock / Drug Safety Armando Oliva / Mary Malarkey / Kenneth I. Shine / Lester M. Crawford / Paul J. Seligman / Jesse L. Goodman / Steven K. Galson / / /
Position
Chair / Assistant Commissioner for Planning / Director for Policy / Acting Director / Deputy Director / Director / Acting Deputy Commissioner for Operations / Acting Commissioner / /
FDA Science Board Advisory Committee Meeting April 15, [removed]Fishers Lane, Room[removed]:30 a.m.